These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 6285388)

  • 1. Prophylactic granulocyte transfusions.
    Buckner CD; Clift RA; Sanders JE; Hersman JA; Williams B
    Prog Clin Biol Res; 1982; 88():93-100. PubMed ID: 6285388
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The effect of granulocyte transfusions on the incidence of cytomegalovirus infection after allogeneic marrow transplantation.
    Hersman J; Meyers JD; Thomas ED; Buckner CD; Clift R
    Ann Intern Med; 1982 Feb; 96(2):149-52. PubMed ID: 6277215
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prophylaxis and treatment of infection of the immunocompromised host by granulocyte transfusions.
    Buckner CD; Clift RA
    Clin Haematol; 1984 Oct; 13(3):557-72. PubMed ID: 6388932
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Multiple granulocyte transfusions facilitating successful unrelated bone marrow transplantation in a patient with very severe aplastic anemia complicated by suspected fungal infection.
    Clarke K; Szer J; Shelton M; Coghlan D; Grigg A
    Bone Marrow Transplant; 1995 Nov; 16(5):723-6. PubMed ID: 8547874
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cytomegalovirus seronegative platelets and leukocyte-poor red blood cells from random donors can prevent primary cytomegalovirus infection after bone marrow transplantation.
    Verdonck LF; de Graan-Hentzen YC; Dekker AW; Mudde GC; de Gast GC
    Bone Marrow Transplant; 1987 Jun; 2(1):73-8. PubMed ID: 2844337
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Current status of leukocyte and platelet administration in cancer therapy.
    Walker EM; Cannon A; Mitchum EN
    Ann Clin Lab Sci; 1983; 13(6):453-73. PubMed ID: 6197928
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Allogeneic bone marrow transplantation.
    Weiden PL
    Crit Rev Clin Lab Sci; 1983; 19(3):173-86. PubMed ID: 6373140
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Controlled study of therapeutic granulocyte transfusions in granulocytopenic patients with severe infections.
    Matsue K; Harada M; Nakao S; Ueda M; Kondo K; Odaka K; Mori T; Hattori K
    Jpn J Clin Oncol; 1984 Mar; 14(1):21-30. PubMed ID: 6368906
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Early infectious complications in allogeneic marrow transplant recipients with acute leukemia: effects of prophylactic measures.
    Buckner CD; Clift RA; Thomas ED; Hersman J; Sanders JE; Stewart PS; Wade JC; Murphy M; Counts G; Meyers JD
    Infection; 1983; 11(5):243-50. PubMed ID: 6417027
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Granulocyte transfusions for the prevention of infection in patients receiving bone-marrow transplants.
    Clift RA; Sanders JE; Thomas ED; Williams B; Buckner CD
    N Engl J Med; 1978 May; 298(19):1052-7. PubMed ID: 417248
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Symposium on infectious complications of neoplastic disease (Part II). Granulocyte transfusions.
    Clift RA; Buckner CD
    Am J Med; 1984 Apr; 76(4):631-6. PubMed ID: 6324588
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Granulocyte transfusions in children.
    Pflieger H; Wiesneth M; Arnold R; Niethammer D; Kleihauer E
    Eur J Pediatr; 1981 Feb; 135(3):261-6. PubMed ID: 7014221
    [No Abstract]   [Full Text] [Related]  

  • 13. Prophylaxis of infection in patients with aplastic anemia receiving allogeneic marrow transplants.
    Navari RM; Buckner CD; Clift RA; Storb R; Sanders JE; Stewart P; Sullivan KM; Williams B; Counts GW; Meyers JD
    Am J Med; 1984 Apr; 76(4):564-72. PubMed ID: 6424464
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The current status of platelet and granulocyte transfusions.
    Seidl S; Kilp M
    Haematologia (Budap); 1980; 13(1-4):145-54. PubMed ID: 7019021
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Granulocyte transfusions in treatment of infections in patients with acute leukaemia and aplastic anaemia.
    Lowenthal RM; Grossman L; Goldman JM; Storring RA; Buskard NA; Park DS; Murphy BC; Spiers AS; Galton DA
    Lancet; 1975 Feb; 1(7903):353-8. PubMed ID: 46510
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The role of a protective environment and prophylactic granulocyte transfusion in marrow transplantation.
    Buckner CD; Clift RA; Sanders JE; Thomas ED
    Transplant Proc; 1978 Mar; 10(1):255-7. PubMed ID: 345564
    [No Abstract]   [Full Text] [Related]  

  • 17. Treatment of aplastic anemia.
    Gale RP
    Tokai J Exp Clin Med; 1985 Jun; 10(2-3):117-26. PubMed ID: 3914736
    [No Abstract]   [Full Text] [Related]  

  • 18. Single-donor granulocyte transfusions for improving the outcome of high-risk pediatric patients with known bacterial and fungal infections undergoing stem cell transplantation: a 10-year single-center experience.
    Nikolajeva O; Mijovic A; Hess D; Tatam E; Amrolia P; Chiesa R; Rao K; Silva J; Veys P
    Bone Marrow Transplant; 2015 Jun; 50(6):846-9. PubMed ID: 25822222
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prophylactic granulocyte transfusions during human bone marrow transplantation.
    Winston DJ; Ho WG; Young LS; Gale RP
    Am J Med; 1980 Jun; 68(6):893-7. PubMed ID: 6247910
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cytomegalovirus infection following marrow transplantation: risk, treatment, and prevention.
    Meyers JD
    Birth Defects Orig Artic Ser; 1984; 20(1):101-17. PubMed ID: 6329356
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.